Skip to content

Author

Mohamed M. Khalifa

We have 1 of 9 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

VEGFR-2 as a druggable target: recent advances (2025) in the development of five-membered heterocyclic anticancer agents.

This comprehensive review systematically examines recent advances in the rational design, synthesis, and biological evaluation of five-membered heterocyclic scaffolds, thiadiazol, oxazole, thiazole, thiazole, and pyrrole, as well as pyrazole and imidazole-based inhibitors as novel VEGFR-2 inhibitors.

Mohamed M. Khalifa, Ibtehal Naseer Salman, Reyadh Jassem · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.